Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research

Open Access statistics for Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Spain, covering academic research published from 2009 to 2024.

Open Access statistics for Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, Spain, covering academic research published from 2009 to 2024. Read More.


Open Access Percentage

74%


Total
Publications

1.3K


Total Open
Publications

931


Total
Citations

36K


Open Access
Percentage

74%


Total
Publications

1.3K


Total Open
Publications

931


Total
Citations

36K

Website

download

Breakdown

11% 53% 8% 28%

Publisher Open

11%

Both

53%

Other Platform Open

8%

Closed

28%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110120130140Total Publications
2009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

52%OA Journal

OA Journal 52%

385

Hybrid 32%

237

No Guarantees 16%

119

Other Platform Open

Institution 83%

608

Domain 67%

491

Other Internet 26%

195

Preprint 8%

58

Public 6%

43

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
546
University of Granada - Institutional Repository of the University of Granada
Institution
339
RISalud Institutional Health Repository of Andalucía
Institution
279
DOI
Other Internet
165
Spanish National Research Council (CSIC - DIGITAL.CSIC)
Institution
56
MDPI
Preprint
56
Europe PMC
Domain
53
DANS - Data Archiving and Networked Services
Institution
52
Unknown Repository
Other Internet
38
University of Edinburgh - Edinburgh Research Explorer
Institution
37
1 / 16

Data updated 18 August 2025

Share

Share

Share